世界の乾癬性関節炎治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Psoriatic Arthritis Therapeutics Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X13817 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、乾癬性関節炎治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。乾癬性関節炎治療薬の種類別市場規模（NF阻害剤、インターロイキン阻害剤、PDE4阻害剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・乾癬性関節炎治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Janssen Biotech、Novartis、Amgen、CELGENE CORPORATION、Pfizer、Eli Lilly、UCB、Biogen、Bristol-Myers Squibb ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：NF阻害剤、インターロイキン阻害剤、PDE4阻害剤、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・乾癬性関節炎治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・乾癬性関節炎治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・乾癬性関節炎治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・乾癬性関節炎治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・乾癬性関節炎治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Psoriatic Arthritis Therapeutics Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Psoriatic Arthritis Therapeutics Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Psoriatic Arthritis Therapeutics Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Psoriatic Arthritis Therapeutics Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
NF Inhibitors
Interleukin Inhibitors
PDE4 Inhibitors
Others

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global Psoriatic Arthritis Therapeutics Drug market are listed below:
AbbVie
Janssen Biotech
Novartis
Amgen
CELGENE CORPORATION
Pfizer
Eli Lilly
UCB
Biogen
Bristol-Myers Squibb

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Psoriatic Arthritis Therapeutics Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Psoriatic Arthritis Therapeutics Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 NF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 PDE4 Inhibitors
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Psoriatic Arthritis Therapeutics Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Psoriatic Arthritis Therapeutics Drug Market Size & Forecast
1.4.1 Global Psoriatic Arthritis Therapeutics Drug Sales in Value (2016-2026))
1.4.2 Global Psoriatic Arthritis Therapeutics Drug Sales in Volume (2016-2026)
1.4.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Psoriatic Arthritis Therapeutics Drug Production Capacity Analysis
1.5.1 Global Psoriatic Arthritis Therapeutics Drug Total Production Capacity (2016-2026)
1.5.2 Global Psoriatic Arthritis Therapeutics Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Psoriatic Arthritis Therapeutics Drug Market Drivers
1.6.2 Psoriatic Arthritis Therapeutics Drug Market Restraints
1.6.3 Psoriatic Arthritis Therapeutics Drug Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Product and Services
2.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Janssen Biotech
2.2.1 Janssen Biotech Details
2.2.2 Janssen Biotech Major Business
2.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product and Services
2.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Product and Services
2.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Product and Services
2.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 CELGENE CORPORATION
2.5.1 CELGENE CORPORATION Details
2.5.2 CELGENE CORPORATION Major Business
2.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product and Services
2.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Product and Services
2.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product and Services
2.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 UCB
2.8.1 UCB Details
2.8.2 UCB Major Business
2.8.3 UCB Psoriatic Arthritis Therapeutics Drug Product and Services
2.8.4 UCB Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Biogen
2.9.1 Biogen Details
2.9.2 Biogen Major Business
2.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Product and Services
2.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product and Services
2.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturer
3.1 Global Psoriatic Arthritis Therapeutics Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Psoriatic Arthritis Therapeutics Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Psoriatic Arthritis Therapeutics Drug Manufacturer Market Share
3.4.2 Top 6 Psoriatic Arthritis Therapeutics Drug Manufacturer Market Share
3.5 Global Psoriatic Arthritis Therapeutics Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Psoriatic Arthritis Therapeutics Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Region
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2016-2026)
4.2 North America Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026)
4.3 Europe Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026)
4.4 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026)
4.5 South America Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026)
4.6 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Psoriatic Arthritis Therapeutics Drug Sales in Volume by Type (2016-2026)
5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2016-2026)
5.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Psoriatic Arthritis Therapeutics Drug Sales in Volume by Application (2016-2026)
6.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2016-2026)
6.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2026)
7.2 North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2026)
7.3 North America Psoriatic Arthritis Therapeutics Drug Market Size by Country
7.3.1 North America Psoriatic Arthritis Therapeutics Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2026)
8.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2026)
8.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country
8.3.1 Europe Psoriatic Arthritis Therapeutics Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Market Size by Region
9.3.1 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2026)
10.2 South America Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2026)
10.3 South America Psoriatic Arthritis Therapeutics Drug Market Size by Country
10.3.1 South America Psoriatic Arthritis Therapeutics Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Market Size by Country
11.3.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Psoriatic Arthritis Therapeutics Drug Typical Distributors
12.3 Psoriatic Arthritis Therapeutics Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Psoriatic Arthritis Therapeutics Drug Product and Services
Table 6. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 8. Janssen Biotech Major Business
Table 9. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product and Services
Table 10. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Psoriatic Arthritis Therapeutics Drug Product and Services
Table 14. Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Amgen Basic Information, Manufacturing Base and Competitors
Table 16. Amgen Major Business
Table 17. Amgen Psoriatic Arthritis Therapeutics Drug Product and Services
Table 18. Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CELGENE CORPORATION Basic Information, Manufacturing Base and Competitors
Table 20. CELGENE CORPORATION Major Business
Table 21. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product and Services
Table 22. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Psoriatic Arthritis Therapeutics Drug Product and Services
Table 26. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product and Services
Table 30. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. UCB Basic Information, Manufacturing Base and Competitors
Table 32. UCB Major Business
Table 33. UCB Psoriatic Arthritis Therapeutics Drug Product and Services
Table 34. UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biogen Basic Information, Manufacturing Base and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Psoriatic Arthritis Therapeutics Drug Product and Services
Table 38. Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 40. Bristol-Myers Squibb Major Business
Table 41. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product and Services
Table 42. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Psoriatic Arthritis Therapeutics Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Psoriatic Arthritis Therapeutics Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Psoriatic Arthritis Therapeutics Drug Production Site of Key Manufacturer
Table 48. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2016-2021e) & (K Units)
Table 49. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2026) & (K Units)
Table 50. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2021e) & (K Units)
Table 53. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (K Units)
Table 54. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Psoriatic Arthritis Therapeutics Drug Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Psoriatic Arthritis Therapeutics Drug Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2021e) & (K Units)
Table 59. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (K Units)
Table 60. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Psoriatic Arthritis Therapeutics Drug Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Psoriatic Arthritis Therapeutics Drug Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2016-2021e) & (K Units)
Table 65. North America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (K Units)
Table 66. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2021e) & (K Units)
Table 69. North America Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (K Units)
Table 70. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2021e) & (K Units)
Table 71. North America Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (K Units)
Table 72. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (K Units)
Table 74. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (K Units)
Table 78. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (K Units)
Table 88. South America Psoriatic Arthritis Therapeutics Drug Sales by Country (2016-2021e) & (K Units)
Table 89. South America Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (K Units)
Table 90. South America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2021e) & (K Units)
Table 93. South America Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (K Units)
Table 94. South America Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2021e) & (K Units)
Table 95. South America Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Psoriatic Arthritis Therapeutics Drug Typical Distributors
Table 107. Psoriatic Arthritis Therapeutics Drug Typical Customers
List of Figures
Figure 1. Psoriatic Arthritis Therapeutics Drug Picture
Figure 2. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type in 2020
Figure 3. NF Inhibitors
Figure 4. Interleukin Inhibitors
Figure 5. PDE4 Inhibitors
Figure 6. Others
Figure 7. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application in 2020
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Psoriatic Arthritis Therapeutics Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Psoriatic Arthritis Therapeutics Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Psoriatic Arthritis Therapeutics Drug Sales (2016-2026) & (K Units)
Figure 33. Global Psoriatic Arthritis Therapeutics Drug Production Capacity (2016-2026) & (K Units)
Figure 34. Global Psoriatic Arthritis Therapeutics Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Psoriatic Arthritis Therapeutics Drug Market Drivers
Figure 36. Psoriatic Arthritis Therapeutics Drug Market Restraints
Figure 37. Psoriatic Arthritis Therapeutics Drug Market Trends
Figure 38. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturer in 2020
Figure 39. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturer in 2020
Figure 40. Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Psoriatic Arthritis Therapeutics Drug Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Psoriatic Arthritis Therapeutics Drug Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2016-2026)
Figure 44. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2016-2026)
Figure 45. North America Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026) & (USD Million)
Figure 46. Europe Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026) & (USD Million)
Figure 48. South America Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue (2016-2026) & (USD Million)
Figure 50. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2016-2026)
Figure 51. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2016-2026)
Figure 52. Global Psoriatic Arthritis Therapeutics Drug Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2016-2026)
Figure 54. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2016-2026)
Figure 55. Global Psoriatic Arthritis Therapeutics Drug Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2016-2026)
Figure 57. North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2016-2026)
Figure 58. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2016-2026)
Figure 59. North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2016-2026)
Figure 60. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2016-2026)
Figure 61. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2016-2026)
Figure 62. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2016-2026)
Figure 63. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2016-2026)
Figure 68. South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2016-2026)
Figure 69. South America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2016-2026)
Figure 70. South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2016-2026)
Figure 71. South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---